Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced chiral resolution technology for 2-heterocyclic dihydropyrimidines using binaphthol phosphate. Delivers >99% optical purity for scalable hepatitis B drug manufacturing.
Novel enzymatic route for S-indoline-2-carboxylic acid ensures >99% ee purity and simplified processing for reliable pharmaceutical intermediate supply chains.
Patent CN105420285B reveals a scalable enzymatic method for producing optically active heptadecene compounds, offering significant cost reduction and supply chain reliability for agrochemical manufacturers.
Patent CN1622932A details a novel ruthenium catalyst for efficient chiral alcohol resolution. Enables cost reduction in pharmaceutical manufacturing via simplified purification.
Discover the advanced Lewis acid-mediated reduction and enzymatic resolution process for high-purity cis-4-O-protected-2-cyclopentenol derivatives used in immunosuppressants.
Patent CN102264715B reveals a scalable cinchonidine salt resolution process for HCV inhibitors, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel Co(III) catalyzed route for Oteseconazole offers high ee value and safety. Reliable supply chain partner for scalable antifungal intermediate manufacturing.
Patent CN102417497A reveals a novel resolution method for Ramelteon intermediates, offering high optical purity and significant cost reduction in pharmaceutical manufacturing.
Advanced acetylation-crystallization method for D-Pantolactone resolution. Delivers 99.5% optical purity with significant cost reduction and stable supply chain capabilities.
This novel chiral resolution method offers high purity and significant cost efficiency for global pharmaceutical intermediate manufacturing supply chains today.
Patent CN1128785C reveals a novel two-step resolution process for high-purity 1-phenylethylamines, offering significant cost reduction and supply chain reliability for agrochemical manufacturing.
Patent CN106520651A details enzymatic L-norvaline production. High purity, scalable process offers supply chain stability and cost efficiency for pharmaceutical manufacturers.
Patent CN108239091B details a robust chemical resolution for NLG919 precursors. This method offers high optical purity, recoverable reagents, and scalable manufacturing for pharmaceutical supply chains.
Patent CN108239091B details a novel chemical resolution for NLG919 precursors, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel isovaleraldehyde route enhances purity and yield. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN102925528B reveals a novel nitrilase-catalyzed route for high-purity levo-praziquantel intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN101622239A reveals a high-yield resolution method for homocysteine-gamma-thiolactone using chiral acids and aromatic aldehydes, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Enzymatic resolution patent CN112442523B enables high-purity chiral intermediate production with reduced costs and scalable supply chain reliability for global pharma.
Patent CN102010400A details a novel chiral resolution route for Rotigotine intermediates, offering high purity and streamlined manufacturing for reliable pharmaceutical supply chains.
Patent CN1220702A details a novel enzymatic process for producing high-purity optically active amines, offering significant cost reduction and supply chain reliability for agrochemical and pharmaceutical intermediates.